AT Bancorp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$508K Sell
3,914
-70
-2% -$8.51K 0.06% 152
2018
Q4
$461K Buy
3,984
+440
+12% +$49.2K 0.06% 155
2018
Q3
$380K Hold
3,544
0.04% 176
2018
Q2
$302K Hold
3,544
0.03% 193
2018
Q1
$274K Hold
3,544
0.03% 201
2017
Q4
$299K Hold
3,544
0.03% 200
2017
Q3
$303K Hold
3,544
0.03% 198
2017
Q2
$292K Hold
3,544
0.03% 210
2017
Q1
$298K Hold
3,544
0.04% 232
2016
Q4
$261K Buy
3,544
+70
+2% +$5.21K 0.03% 242
2016
Q3
$279K Hold
3,474
0.04% 234
2016
Q2
$274K Hold
3,474
0.04% 212
2016
Q1
$250K Hold
3,474
0.04% 211
2015
Q4
$293K Hold
3,474
0.08% 165
2015
Q3
$291K Hold
3,474
0.08% 163
2015
Q2
$290K Hold
3,474
0.07% 168
2015
Q1
$252K Sell
3,474
-150
-4% -$10.7K 0.07% 182
2014
Q4
$250K Hold
3,624
0.07% 176
2014
Q3
$235K Hold
3,624
0.07% 184
2014
Q2
$225K Hold
3,624
0.07% 183
2014
Q1
$213K Buy
+3,624
New +$202K 0.07% 177

Other funds holding LLY

AT Bancorp's LLY Position: Q1 2019 in Review

AT Bancorp reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2019, selling an estimated $8.51K and leaving 3,914 shares worth $508K. The position accounts for 0.06% of the portfolio, ranked #152.

AT Bancorp first reported a position in LLY in Q1 2014 and has held it in 21 quarters since. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.

  • AT Bancorp held 3,914 shares of Eli Lilly worth $508K as of Q1 2019.
  • AT Bancorp sold 70 Eli Lilly shares in Q1 2019, an estimated $8.51K.
  • Eli Lilly made up 0.06% of AT Bancorp's portfolio in Q1 2019, its #152 holding.
  • AT Bancorp first reported a position in Eli Lilly in Q1 2014 and has held it in 21 quarters since.
  • 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.